Verition Fund Management LLC raised its stake in ICU Medical, Incorporated (NASDAQ:ICUI) by 452.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,168 shares of the medical instruments supplier’s stock after acquiring an additional 4,233 shares during the quarter. Verition Fund Management LLC’s holdings in ICU Medical were worth $1,518,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Brinker Capital Inc. boosted its stake in ICU Medical by 2.6% in the first quarter. Brinker Capital Inc. now owns 8,097 shares of the medical instruments supplier’s stock valued at $2,044,000 after acquiring an additional 205 shares during the last quarter. Retirement Systems of Alabama raised its position in shares of ICU Medical by 1.1% in the second quarter. Retirement Systems of Alabama now owns 19,732 shares of the medical instruments supplier’s stock valued at $5,794,000 after purchasing an additional 206 shares during the period. Baird Financial Group Inc. raised its position in shares of ICU Medical by 0.5% in the second quarter. Baird Financial Group Inc. now owns 49,781 shares of the medical instruments supplier’s stock valued at $14,618,000 after purchasing an additional 245 shares during the period. Suntrust Banks Inc. raised its position in shares of ICU Medical by 2.1% in the first quarter. Suntrust Banks Inc. now owns 14,926 shares of the medical instruments supplier’s stock valued at $3,767,000 after purchasing an additional 309 shares during the period. Finally, Violich Capital Management Inc. raised its position in shares of ICU Medical by 27.6% in the second quarter. Violich Capital Management Inc. now owns 1,537 shares of the medical instruments supplier’s stock valued at $451,000 after purchasing an additional 332 shares during the period. Hedge funds and other institutional investors own 74.29% of the company’s stock.

Several analysts have recently issued reports on ICUI shares. TheStreet raised shares of ICU Medical from a “c+” rating to a “b+” rating in a research report on Monday, August 20th. ValuEngine lowered shares of ICU Medical from a “strong-buy” rating to a “buy” rating in a report on Friday, August 3rd. BidaskClub raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Friday, September 28th. Finally, Zacks Investment Research lowered shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a report on Thursday. One research analyst has rated the stock with a hold rating and two have given a buy rating to the stock. ICU Medical currently has an average rating of “Buy” and a consensus target price of $337.00.

In other news, Director Pfizer Inc sold 700,000 shares of the stock in a transaction on Monday, August 13th. The shares were sold at an average price of $284.35, for a total value of $199,045,000.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Virginia Ruth Sanzone sold 787 shares of the stock in a transaction on Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total transaction of $238,555.44. Following the completion of the transaction, the vice president now directly owns 1,367 shares in the company, valued at approximately $414,365.04. The disclosure for this sale can be found here. Insiders sold a total of 711,920 shares of company stock worth $202,651,956 in the last three months. Insiders own 12.50% of the company’s stock.

ICU Medical stock traded up $4.95 during midday trading on Friday, reaching $265.80. 167,031 shares of the stock were exchanged, compared to its average volume of 157,986. The firm has a market capitalization of $5.79 billion, a PE ratio of 48.15 and a beta of 0.41. ICU Medical, Incorporated has a 52 week low of $180.45 and a 52 week high of $321.70.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, August 9th. The medical instruments supplier reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.82 by $0.84. The business had revenue of $360.46 million for the quarter, compared to analyst estimates of $337.60 million. ICU Medical had a net margin of 5.93% and a return on equity of 12.78%. ICU Medical’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.76 EPS. As a group, research analysts anticipate that ICU Medical, Incorporated will post 7.6 earnings per share for the current year.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: How to Use a Moving Average for Trading 

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.